Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 39 - General protective or antinoxious agents
Patents for A61P 39 - General protective or antinoxious agents (19,019)
01/1999
01/21/1999WO1999002163A1 Inhibitors of neutrophil mediated oxidant production
01/21/1999CA2296017A1 Method for producing calcium pyruvates
01/21/1999CA2295697A1 Inhibitors of neutrophil mediated oxidant production
01/21/1999CA2295218A1 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same
01/20/1999EP0891422A1 Complex superoxide dismutase product
01/20/1999CN1205704A 2,7-substituted octahydro-pyrrolo (1,2-A) pyrazine derivatives
01/14/1999DE19729544A1 Ancrod spezifische monoklonale Antikörper, Antikörperfragmente, deren Mischung oder Derivate und deren Verwendung Ancrod specific monoclonal antibodies, antibody fragments, their mixture or their derivatives and the use thereof
01/12/1999US5859271 Inhibitors of phospholipase that prevent phospholipase mediated injury, injury due to oxidation, and inflammation; side effect reduction
01/12/1999US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase
01/12/1999US5858402 Administering physiologically compatible transition metal chelate of dithiocarbamate-containing cyanide scavenger
01/07/1999EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase
01/07/1999EP0888290A1 Azulenyl nitrone spin trapping agents, methods of making and using same
01/07/1999EP0888267A1 Novel pyruvate compounds and methods for use thereof
01/07/1999EP0672127B1 Use of thiol redox proteins for reducing disulfide bonds
01/05/1999US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase
01/05/1999US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase
01/03/1999CA2236462A1 Murc
12/1998
12/30/1998WO1998058938A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
12/30/1998WO1998058922A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
12/30/1998WO1998058676A1 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative
12/30/1998WO1998058635A2 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis
12/30/1998CA2294601A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
12/30/1998CA2293327A1 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis
12/29/1998US5854055 Recombinant mycobacteria
12/29/1998US5853699 Use of tetra azacycle complexes as x-ray diagnostic agents for the liver and gallbladder
12/23/1998WO1998045241A3 Lutein esters having high bioavailability
12/23/1998EP0885241A1 Purification method
12/23/1998EP0885013A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
12/23/1998EP0607222B1 Dendrimeric polychelants
12/17/1998WO1998056829A1 Method for fixing or separating ions, in particular of lead, using per(3,6-anhydro) cyclodextrin derivatives
12/16/1998EP0884316A1 Quinazoline-4-one AMPA antagonists
12/15/1998US5849930 Pyrazolidine derivative radical scavenger brain-infarction depressant and brain-edema depressant
12/10/1998WO1998014216A3 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/03/1998WO1998053844A1 Pharmaceutical compostions of peptides having low solubility in physiological medium
12/03/1998CA2291765A1 Pharmaceutical compositions of peptides having low solubility in physiological medium
12/02/1998EP0880969A1 Pharmaceutical compositions of peptides having low solubility in physiological medium
12/02/1998CN1200674A Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens
12/02/1998CN1200282A Medicine for eliminating toxicity and side-effect casused by chemotherapy during treating cancer
12/01/1998CA2104381C Production and use of butyrylcholinesterase
11/1998
11/26/1998WO1998052973A1 New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
11/26/1998WO1998052598A1 Novel administration of thrombopoietin
11/26/1998CA2288964A1 Novel administration of thrombopoietin
11/25/1998EP0879596A2 Use of cholinesterase inhibitors to reduce benzodiazepine side effects
11/25/1998EP0619808B1 3-hydroxypyridin-4-one derivatives as chelating agents
11/24/1998US5840722 Administering to inhibit endothelin receptors
11/19/1998WO1998051679A1 Tocopherol esters and their cosmetic and pharmaceutical uses
11/19/1998WO1998051348A2 Sustained-release delayed gels
11/19/1998WO1998051244A1 Intrauterine chemical necrosing method, composition, and apparatus
11/19/1998WO1998051217A1 Vaccine against lipopolysaccharide core
11/19/1998CA2289760A1 Vaccine against lipopolysaccharide core
11/18/1998EP0878199A1 Natural teas for taking off the effects of drink and process for the production thereof
11/17/1998US5837677 Method for the treatment of cancer with Exochelins of Mycobacterium tuberculosis
11/12/1998WO1998050059A1 Method for preventing gastritis using amylin or amylin agonists
11/12/1998CA2289548A1 Method for preventing gastritis using amylin or amylin agonists
11/11/1998EP0876151A1 Microencapsulated genetically engineered microorganisms for clinical application
11/11/1998EP0876140A2 Improved concentrated injection and infusion solutions for intravenous administration
11/11/1998CN1040646C Enatiomeric hydroxylated xanthine compound
11/10/1998US5834448 Dosage form of hydroxocobalamin and its use in cyanide poisoning
11/05/1998WO1998049154A1 Alpha-tocopherol 4-aminobenzoic acid ester compounds and method for preparing the same
11/05/1998WO1998049129A1 Conjugated linolenic acid-based synthetic triglycerides
11/05/1998WO1998032863A3 Mammalian thioredoxin
11/04/1998EP0874849A1 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives
11/03/1998USRE35948 Pharmaceutical compositions
11/03/1998US5830492 Matrix containing a hormone encapsulated with polymer
11/03/1998US5830436 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
10/1998
10/29/1998WO1998047489A1 Sustained-release compositions and method for preparing same
10/28/1998EP0873755A1 Prevention and treatment of enterohemorrhagic E. coli infection
10/27/1998US5827880 Salen-metal complexes
10/27/1998US5827816 Bactericide for gram-negative bacteria infection; a polypeptide with a cysteine at position 132 replaced by different amino acid
10/23/1998CA2235457A1 Prevention and treatment of enterohemorrhagic e. coli infection
10/21/1998EP0871608A1 Novel monofunctionalised edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
10/21/1998EP0871448A1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase
10/20/1998US5824297 Administering transforming growth factor beta to cancer patients before chemotherapy; side effect reduction of oraland gastrointestinal mucositis
10/15/1998WO1998045241A2 Lutein esters having high bioavailability
10/14/1998CN1196050A Cyclic nitrones and pharmaceutical compositions containing them
10/14/1998CN1195522A Use of 2(3) tertiary butyl-4-hydroxy-anisole in preparation of drug for preventing and curing tissue organ traumatic disease
10/13/1998US5821266 Antioxidant activity of 3-dehydroshinkimates
10/13/1998US5821219 Opioid antagonists and methods of their use
10/08/1998WO1998044128A1 Novel human serine carboxypeptidase
10/08/1998WO1998043990A1 Gallic acid ester derivatives and drugs containing the same as the active ingredient
10/08/1998WO1998043641A1 Pharmaceutical, cosmetic and/or food composition with antioxidant properties
10/08/1998CA2293359A1 Pharmaceutical, cosmetic and/or food composition with antioxidant properties
10/08/1998CA2283799A1 Novel human serine carboxypeptidase
10/06/1998US5817659 Stable crystalline tetrahydrofolic acid salts
10/01/1998WO1998042846A1 Methods to detect granulocytic ehrlichiosis
10/01/1998WO1998042701A1 3-oxadiazolylquinoxaline derivatives
09/1998
09/29/1998US5814480 Polynucleotide sequence, for detection of the polypeptide in a biological sample
09/23/1998EP0865288A2 Bioartificial devices and cellular matrices therefor
09/22/1998US5811549 Process of preparing imidazole compounds
09/22/1998CA2054471C Aminoglycoside composition having substantially reduced nephrotoxicity induced by the amino glycoside
09/17/1998WO1998040088A1 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents
09/16/1998EP0863878A1 Cyclic nitrones and pharmaceutical compositions containing them
09/16/1998EP0710230B1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
09/15/1998US5807859 Antiischemic agents; brain disorders
09/11/1998WO1998031795A3 Novel human metallothionein
09/09/1998EP0862457A1 Infusions of neuroprotectants and thrombolytic agents
09/08/1998US5804555 Lactoferrin hydrolyzate mixed with oxidation preventing agent(s); food and drug safe
09/02/1998EP0861319A1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx
09/02/1998CN1192160A Chelating polymers as contrast agents for medical imaging
09/02/1998CN1192149A Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides
1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 191